| Attribute |
Value |
| 52 Week Change |
-0.4437173 |
| Address1 |
12,526 High Bluff Drive |
| Address2 |
Suite 345 |
| All Time High |
451.32 |
| All Time Low |
3.9 |
| Ask |
6.02 |
| Ask Size |
2 |
| Audit Risk |
9 |
| Average Daily Volume10 Day |
12,700 |
| Average Daily Volume3 Month |
13,351 |
| Average Volume |
13,351 |
| Average Volume10Days |
12,700 |
| Bid |
3.32 |
| Bid Size |
2 |
| Board Risk |
8 |
| Book Value |
12.596 |
| City |
San Diego |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
10 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
4.24 |
| Current Ratio |
21.468 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
4.25 |
| Day Low |
4.0549 |
| Debt To Equity |
1.346 |
| Display Name |
ImageneBio |
| Dividend Yield |
0.0 |
| Ebitda |
-58,366,500 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
1.475 |
| Enterprise Value |
-86,110,824 |
| Eps Current Year |
-3.31 |
| Eps Forward |
-4.31 |
| Eps Trailing Twelve Months |
-4.09 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
5.1206 |
| Fifty Day Average Change |
-0.88060045 |
| Fifty Day Average Change Percent |
-0.17197211 |
| Fifty Two Week Change Percent |
-44.37173 |
| Fifty Two Week High |
9.1 |
| Fifty Two Week High Change |
-4.8600006 |
| Fifty Two Week High Change Percent |
-0.53406596 |
| Fifty Two Week Low |
3.9 |
| Fifty Two Week Low Change |
0.33999968 |
| Fifty Two Week Low Change Percent |
0.0871794 |
| Fifty Two Week Range |
3.9 - 9.1 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,616,765,400,000 |
| Float Shares |
5,834,875 |
| Forward Eps |
-4.31 |
| Forward P E |
-0.9837587 |
| Free Cashflow |
-23,211,624 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
18 |
| Fullday Change |
-0.099999905 |
| Fullday Change Percent |
-2.352939 |
| Fullday Price |
4.24 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,790,812,800 |
| Gross Margins |
0.0 |
| Gross Profits |
0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.16192 |
| Held Percent Institutions |
0.54594004 |
| Implied Shares Outstanding |
11,351,456 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,753,660,800 |
| Last Split Factor |
1:12 |
| Long Business Summary |
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California. |
| Long Name |
ImageneBio, Inc. |
| Market |
us_market |
| Market Cap |
48,130,172 |
| Market State |
POSTPOST |
| Max Age |
86,400 |
| Message Board Id |
finmb_689254445 |
| Most Recent Quarter |
1,782,777,600 |
| Name Change Date |
2,026-10-13 |
| Net Income To Common |
-53,330,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
54,941,047 |
| Number Of Analyst Opinions |
3 |
| Open |
4.16 |
| Operating Cashflow |
-52,586,000 |
| Operating Margins |
0.0 |
| Overall Risk |
10 |
| Phone |
858 345 6265 |
| Prev Name |
Inmagene Biopharmaceuticals Co. Ltd. |
| Previous Close |
4.25 |
| Price Eps Current Year |
-1.2809668 |
| Price Hint |
4 |
| Price To Book |
0.3366148 |
| Price To Sales Trailing12 Months |
Infinity |
| Profit Margins |
0.0 |
| Quick Ratio |
20.714 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.0100002 |
| Regular Market Change Percent |
-0.2353 |
| Regular Market Day High |
4.25 |
| Regular Market Day Low |
4.0549 |
| Regular Market Day Range |
4.0549 - 4.25 |
| Regular Market Open |
4.16 |
| Regular Market Previous Close |
4.25 |
| Regular Market Price |
4.24 |
| Regular Market Time |
1,791,921,601 |
| Regular Market Volume |
10,117 |
| Return On Assets |
-0.43057 |
| Return On Equity |
-0.82677 |
| Revenue Per Share |
0.0 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
10 |
| Shares Outstanding |
11,351,456 |
| Shares Percent Shares Out |
0.0029 |
| Shares Short |
32,852 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
39,412 |
| Short Name |
ImageneBio, Inc. |
| Short Percent Of Float |
0.0029 |
| Short Ratio |
1.94 |
| Source Interval |
15 |
| State |
CA |
| Symbol |
IMA |
| Target High Price |
28.0 |
| Target Low Price |
2.0 |
| Target Mean Price |
18.0 |
| Target Median Price |
24.0 |
| Total Cash |
136,152,992 |
| Total Cash Per Share |
11.994 |
| Total Debt |
1,912,000 |
| Total Revenue |
0 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-4.09 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
5.808185 |
| Two Hundred Day Average Change |
-1.5681853 |
| Two Hundred Day Average Change Percent |
-0.26999575 |
| Type Disp |
Equity |
| Volume |
10,117 |
| Website |
https://www.inmagenebio.com |
| Zip |
92,130 |